期刊文献+

胰高血糖素样肽介导运动抗抑郁作用的潜在机制 被引量:2

Potential Mechanisms of GLP-Mediated Antidepressant Effects of Exercise
下载PDF
导出
摘要 胰高血糖素样肽-1(GLP-1)是机体在响应营养摄入时而释放的一类肠促胰岛素,主要由肠道末端L细胞分泌,是目前治疗糖尿病的重要靶点。近年来,研究发现:GLP-1受体不仅在肠、胰腺等外周组织中表达,而且在海马、下丘脑等脑组织中也大量表达,这暗示其可能在糖尿病的并发疾病——抑郁症中发挥作用;但GLP-1易被二肽基肽酶Ⅳ降解失活,难以发挥作用,而长期运动可增加GLP-1的表达和分泌。基于此,旨在探究运动介导GLP-1调控抑郁行为的可能机制,进而为运动的抗抑郁机制研究提供新的视角。通过对相关领域文献资料的梳理分析发现,GLP-1介导运动的抗抑郁作用涉及HPA轴激活、中枢单胺类神经递质、中枢营养因子及中枢炎症因子的水平4个维度。由此推论,GLP-1可能是运动发挥抗抑郁作用的重要介质,从而为抑郁症的能量代谢机制和治疗策略提供了新的靶点和阐释路径。 Glucagon-like peptide-1(GLP-1), mainly secreted by L cells, is a kind of incretin hormone released by the body in response to nutritional intake and an important target for the treatment of diabetes.Recent studies have found that GLP-1 receptor is not only expressed in intestinal and pancreatic, but also in the hippocampus and hypothalamus, suggesting its role in depression accompany with diabetes. However,GLP-1 can be degradated by dipeptidyl peptidase Ⅳ, thus being difficult to work, while long term exercise can increase the expression and secretion of GLP-1. Therefore, the current study aimed to explore potential mechanisms of GLP-mediated antidepressant effects of exercise, and to provide a new perspective for exercise effects on depression. The available documents demonstrate that the activation of HPA axis, the expression of central monoamine neurotransmitters, neurotrophic factor and central inflammatory cytokines are involved in the antidepressant effects. To sum up, GLP-1 may be a mediator of exercise effects on depression, which suggests a novel target and pathway of energy metabolism and treatment strategy for depression.
出处 《首都体育学院学报》 CSSCI 北大核心 2017年第5期474-480,共7页 Journal of Capital University of Physical Education and Sports
基金 "青少年健康评价与运动干预"教育部重点实验室开放课题基金(No.11000-541235-90095)
关键词 抑郁症 胰高血糖素样肽 运动 HPA轴 单胺类神经递质 神经营养因子 炎症 depression glucagon-like peptide exercises HPA axis monoamine neurotransmitters neurotrophic factors inflammation
  • 相关文献

参考文献2

二级参考文献36

  • 1BERLIE H, HURREN K M, PINELLI N R. Glucagon-like peptide-lreceptor agonists as add-on therapy to basal insulin in pa- tients with type 2 diabetes: a systematic review[J]. Diabetes Metab Syndr Obes, 2012,5 : 165-174.
  • 2BOELENS P G, NUVELDT R J, HOUDIJK A P, et al. Glutamine alimentation in catabolic state[J]. J Nutr,2001,131(9 Sup pl) : 2569S-2577S.
  • 3DEFRONZO R A, ABDUL-GHANI M. Type 2 diabetes can be prevented with early pharmacological intervention[J]. Diabetes Care, 2011,34 Suppl2 :S202-209.
  • 4GREENFIELD J R, FAROOQI I S, KEOGH J M, et al. Oral glutamine increases circulating glucagon like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects[J]. Am J Clin Nutr,2009,89(1) :106-113.
  • 5GOLBIDI S, MESDAGHINIA A, LAHER I. Exercise in the metabolic syndrome[J]. Oxid Med Cell Longer, 2012, ArticleID349710:1-13.
  • 6HANSEN K B, VILSBOLL T, KNOP F K. Incretin mimetics., a novel therapeutic option for patients with type 2 diabetes-a review[J]. Diabetes Metab Syndr Obes, 2010,3 : 155-163.
  • 7KLINKE A, NUSSBAUM C, KUBALA L, et al. Myeloperoxidase attracts neutrophils by physical forces[J]. Blood, 2011,117 (4) : 1350-1358.
  • 8MALLE E, FURTMULLER P G, SATTLER W, et al. Myeloperoxidase: a target for new drug development [J]. Br J Pharmacol, 2007,152 (6)"838-854.
  • 9MARTINS C, MORGAN L M, BLOOM S R, et al. Effects of exercise on gut peptides, energy intake and appetite[J]. J Endocrinol, 2007,193 (2) : 251-258.
  • 10MATES J M, PEREZ-GOMEZ C, NUNEZ DE CASTRO I, et al. Glutamine and its relationship with intracellular redox status,oxidative stress and cell proliferation/death[J]. Int J Biochem Cell Biol, 2002,34(5) : 439-458.

共引文献21

同被引文献31

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部